CytoDyn Inc.
CYDY
$0.25
-$0.01-2.40%
OTC PK
| 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 4.98M | 9.33M | 11.90M | 16.40M | 21.34M |
| Total Receivables | -- | -- | 2.00M | 2.00M | 2.00M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 560.00K | 560.00K | 252.00K | 513.00K | 635.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 3.30M | 3.46M | 3.72M | 2.07M | 663.00K |
| Total Current Assets | 8.84M | 13.35M | 17.88M | 20.98M | 24.63M |
|
|
|||||
| Total Current Assets | 8.84M | 13.35M | 17.88M | 20.98M | 24.63M |
| Net Property, Plant & Equipment | 65.00K | 98.00K | 130.00K | 163.00K | 196.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 31.00K | 35.00K | 39.00K | 44.00K | 48.00K |
| Total Assets | 8.94M | 13.48M | 18.05M | 21.19M | 24.88M |
|
|
|||||
| Total Accounts Payable | 14.25M | 14.18M | 14.69M | 15.13M | 14.24M |
| Total Accrued Expenses | 34.59M | 19.30M | 20.22M | 20.26M | 20.18M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 27.27M | 27.31M | 27.34M | 27.28M | 28.67M |
| Total Finance Division Other Current Liabilities | 9.01M | 8.64M | 8.27M | 7.90M | 7.53M |
| Total Other Current Liabilities | 9.01M | 8.64M | 8.27M | 7.90M | 7.53M |
| Total Current Liabilities | 85.11M | 69.42M | 70.52M | 70.57M | 70.63M |
|
|
|||||
| Total Current Liabilities | 85.11M | 69.42M | 70.52M | 70.57M | 70.63M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | 34.00K | 69.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 43.57M | 43.57M | 43.57M | 43.57M | 43.57M |
| Total Liabilities | 128.68M | 112.99M | 114.09M | 114.17M | 114.27M |
|
|
|||||
| Common Stock & APIC | 796.19M | 793.82M | 791.74M | 788.85M | 787.68M |
| Retained Earnings | -915.93M | -893.33M | -887.79M | -881.83M | -877.07M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -119.75M | -99.51M | -96.04M | -92.98M | -89.39M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -119.75M | -99.51M | -96.04M | -92.98M | -89.39M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -119.75M | -99.51M | -96.04M | -92.98M | -89.39M |
|
|
|||||